Manufacturing

Showing 1–12 of 83 results

The past 25 years have seen a steady progression in business relationships between CDMOs and drug developers. The initial focus of identifying supply chain inefficiencies has advanced from controlling fixed costs and capacity fluctuations to gaining access to specific technologies, skills, and scientific expertise not possessed in-house. Our market research helps drug innovators understand the dynamic drug manufacturing environment, identify the right type of outsourcing model to best meet their organizations’ needs, and make smarter CDMO selection decisions based on hard data collected from outsourcing peers.

  • Select options

    Sterile Injectable Drug Product Manufacturing Market Outlook: 2023-2028

    $5,650.00 – $11,300.00
  • Select options

    Cell & Gene Therapies Manufacturing Market Outlook (2nd Edition)

    $5,650.00 – $11,300.00
  • Select options

    Biologic Drug Product CDMO Benchmarking (6th Ed.)

    $6,750.00 – $13,500.00
  • Select options

    Small Molecule Drug Product CDMO Benchmarking (6th Ed.)

    $6,750.00 – $13,500.00
  • Select options

    Biologic API CDMO Benchmarking (8th Ed.)

    $6,750.00 – $13,500.00
  • Select options

    Small Molecule API CDMO Benchmarking (8th Ed.)

    $6,750.00 – $13,500.00
  • Select options

    Clinical Manufacturing Market Outlook

    $5,650.00 – $11,300.00
  • Select options

    Small and Midsize Biopharma Perspective on the Highly Potent API Manufacturing Market

    $4,550.00 – $9,100.00
  • Select options

    Clinical Logistics Benchmarking

    $6,750.00 – $13,500.00
  • Select options

    CDMO Outsourcing Models (4th Ed.)

    $5,650.00 – $11,300.00
  • Select options

    Bioprocessing Market Outlook: 2022-2027

    $5,650.00 – $11,300.00
  • Select options

    Clinical Logistics Market Dynamics

    $5,650.00 – $11,300.00